Pfizer’s quit smoking drug raises heart risks by 72 percent
• RawStory.comHealthy, middle-aged smokers who take Pfizer's Chantix or Champix, one of the most popular quit-smoking drugs on the market, have a higher risk of suffering heart attacks or other serious heart problems, a study found on Monday.